Aurora SpineASAPF 40 Market Cap is $12.69 Mil as of Jun. 24, 2026. GuruFocus rates ASAPF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Aurora Spine ranks worse than 83.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aurora Spine's share price for the quarter that ended in Mar. 2026 was $0.207. Aurora Spine's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 78.09 Mil. Therefore, Aurora Spine's market cap for the quarter that ended in Mar. 2026 was $16.17 Mil.
Aurora Spine's quarterly market cap
declined
from Sep. 2025 ($16.78 Mil) to Dec. 2025 ($15.62 Mil) but then
increased
from Dec. 2025 ($15.62 Mil) to Mar. 2026 ($16.17 Mil).
Aurora Spine's annual market cap
declined
from Dec. 2023 ($22.45 Mil) to Dec. 2024 ($21.65 Mil) and
declined
from Dec. 2024 ($21.65 Mil) to Dec. 2025 ($15.62 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aurora Spine's Enterprise Value for Today is $15.43 Mil.
Aurora Spine (OTCPK:ASAPF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Aurora Spine Market Cap Related Terms
Aurora Spine Market Cap Historical Data
* Premium members only.
The historical data trend for Aurora Spine's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aurora Spine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Market Cap distribution charts can be found below:
* The bar in red indicates where Aurora Spine's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Aurora Spine's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Spine (ASAPF) has a Market Cap of $12.69 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #721 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 83.3%.
Is Aurora Spine's Market Cap too high?
Aurora Spine's current Market Cap is $12.69 Mil. The Medical Devices & Instruments industry median Market Cap is 122.09. Aurora Spine's value of $12.69 Mil is 89.6% below this industry median. Based on the distribution chart, Aurora Spine ranks #721 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aurora Spine has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #721 out of 866 companies for Market Cap. This places Aurora Spine in the lower half of its industry. The industry median Market Cap is 122.09. Aurora Spine's value of $12.69 Mil is 89.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.09, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current Market Cap of $12.69 Mil is 89.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current Market Cap is $12.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.16 — trading 29.5% below its estimated fair value. The current Market Cap is $12.69 Mil and 89.6% below the Medical Devices & Instruments industry median of 122.09. Aurora Spine's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Market Cap is $12.69 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.16 is trading 29.5% below its estimated GF Value™ of $0.22.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
Market Cap: $12.69 Mil
GF Value™: $0.22 vs. price of $0.16 (29.5% below fair value)
Industry Position: 89.6% below the Medical Devices & Instruments median (#721 of 866)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
40GF Score
Get the complete analysis for ASAPF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
